159 related articles for article (PubMed ID: 1683496)
21. Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers.
Winship PR; Rees DJ; Alkan M
Lancet; 1989 Mar; 1(8639):631-4. PubMed ID: 2564457
[TBL] [Abstract][Full Text] [Related]
22. Detection of the Taq 1 polymorphism of the factor IX gene by P.C.R.
Mercier B; Gaucher C; Mazurier C
Thromb Res; 1991 Jun; 62(5):599-601. PubMed ID: 1680249
[No Abstract] [Full Text] [Related]
23. Prenatal and molecular diagnosis of hemophilia B.
Young JH; Wang JC; Gau JP; Hu HT
Am J Hematol; 1996 Aug; 52(4):243-7. PubMed ID: 8701940
[TBL] [Abstract][Full Text] [Related]
24. Genetic basis and carrier detection of hemophilia B of Chinese origin.
Lin SW; Shen MC
Thromb Haemost; 1993 Mar; 69(3):247-52. PubMed ID: 8470048
[TBL] [Abstract][Full Text] [Related]
25. Factor IX gene mutations causing haemophilia B: comparison of SSC screening versus systematic DNA sequencing and diagnostic applications.
Aguilar-Martinez P; Romey MC; Schved JF; Gris JC; Demaille J; Claustres M
Hum Genet; 1994 Sep; 94(3):287-90. PubMed ID: 8076946
[TBL] [Abstract][Full Text] [Related]
26. Screening for mutations in the gene encoding factor IX.
Nielsen LR; Schwartz M; Scheibel E
J Inherit Metab Dis; 1992; 15(3):339-41. PubMed ID: 1357229
[No Abstract] [Full Text] [Related]
27. Carrier detection and feasibility of prenatal diagnosis of hemophilia B by multiplex polymerase chain reaction.
Tagliavacca L; Sacchi E; Mannucci PM
Int J Clin Lab Res; 1993; 23(3):169-71. PubMed ID: 8104543
[TBL] [Abstract][Full Text] [Related]
28. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.
Lozier JN; Monroe DM; Stanfield-Oakley S; Lin SW; Smith KJ; Roberts HR; High KA
Blood; 1990 Mar; 75(5):1097-104. PubMed ID: 2306516
[TBL] [Abstract][Full Text] [Related]
29. Direct detection of the deletion-insertion polymorphism of the factor IX gene by analysis of amplified DNA sequences (PCR).
Hanauer A; de la Salle C
Thromb Res; 1990 Jul; 59(1):219-20. PubMed ID: 1975958
[No Abstract] [Full Text] [Related]
30. A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York.
Driscoll MC; Bouhassira E; Aledort LM
Blood; 1989 Aug; 74(2):737-42. PubMed ID: 2752145
[TBL] [Abstract][Full Text] [Related]
31. Human factor IXLincoln Park: a molecular characterization.
Rao KJ; Lyman G; Hamsbhushanam K; Scott JP; Jagadeeswaran P
Mol Cell Probes; 1990 Oct; 4(5):335-40. PubMed ID: 1980717
[TBL] [Abstract][Full Text] [Related]
32. Use of a BamHI polymorphism in the factor IX gene for the determination of hemophilia B carrier status.
Hay CW; Robertson KA; Yong SL; Thompson AR; Growe GH; MacGillivray RT
Blood; 1986 May; 67(5):1508-11. PubMed ID: 3008893
[TBL] [Abstract][Full Text] [Related]
33. Biology of inherited coagulopathies: factor IX.
Larson PJ; High KA
Hematol Oncol Clin North Am; 1992 Oct; 6(5):999-1009. PubMed ID: 1356960
[TBL] [Abstract][Full Text] [Related]
34. Allele frequencies of two polymorphisms associated with the factor IX gene in Iranian population.
Ghandil P; Ghadiri A; Farhud D; Zeinali S
Thromb Res; 2004; 113(5):289-93. PubMed ID: 15183040
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of haemophilia B using the polymerase chain reaction.
Reiss J; Neufeldt U; Wieland K; Zoll B
Blut; 1990 Jan; 60(1):31-6. PubMed ID: 1967542
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis impact on the genetic counseling of sporadic hemophilia B families.
Bicocchi MP; Pasino M; Bottini F; Lanza T; Mori PG; Acquila M
Am J Med Genet A; 2003 May; 118A(4):328-31. PubMed ID: 12687663
[TBL] [Abstract][Full Text] [Related]
37. [Gene diagnosis and carrier detection of hemophilia B by using genomic amplification with transcripts sequencing].
Liu J; Xiang H; Liu L
Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):599-601, 638-9. PubMed ID: 8697074
[TBL] [Abstract][Full Text] [Related]
38. [Educational symposium: DNA diagnosis of malignancies; strategies and applications of PCR-mediated DNA diagnosis in a case of hemophilia B].
Kojima T
Rinsho Byori; 1998 Sep; 46(9):861-8. PubMed ID: 9800470
[TBL] [Abstract][Full Text] [Related]
39. Carrier testing in hemophilia B with an immunoassay that distinguishes a prevalent factor IX dimorphism.
Smith KJ; Thompson AR; McMullen BA; Frazier D; Lin SW; Stafford D; Kisiel W; Thibodeau SN; Chen SH; Smith LF
Blood; 1987 Oct; 70(4):1006-13. PubMed ID: 3651597
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
